Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,936 | 56,605 | 56,766 | 40,604 | 50,942 |
| Marketable Securities | 131,699 | 154,265 | 154,701 | 162,380 | 147,588 |
| Receivables | 7,498 | 5,511 | 5,276 | 3,412 | 1,613 |
| Inventories | 5,202 | 5,121 | 5,176 | 3,768 | 2,455 |
| TOTAL | $209,800 | $228,373 | $226,304 | $214,979 | $206,090 |
| Non-Current Assets | |||||
| PPE Net | 3,294 | 3,652 | 3,972 | 2,809 | 3,296 |
| Investments And Advances | 0 | 0 | 21,730 | 53,293 | 88,125 |
| Other Non-Current Assets | 10,132 | 2,789 | 5,114 | 5,165 | 877 |
| TOTAL | $13,426 | $6,441 | $30,816 | $61,267 | $92,298 |
| Total Assets | $223,226 | $234,814 | $257,120 | $276,246 | $298,388 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,527 | 1,664 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 10,242 | 6,570 | 8,982 | 7,823 | 8,132 |
| Accrued Expenses | 16,609 | 15,530 | 15,359 | 13,124 | 12,353 |
| Other current liabilities | 1,452 | 512 | 957 | 735 | 435 |
| TOTAL | $29,830 | $24,276 | $25,298 | $21,682 | $20,920 |
| Non-Current Liabilities | |||||
| Long Term Debt | 119,661 | 117,457 | 115,353 | 111,283 | 107,105 |
| Other Non-Current Liabilities | 9,819 | 3,196 | 2,073 | 721 | 760 |
| TOTAL | $129,480 | $120,653 | $117,426 | $112,004 | $107,865 |
| Total Liabilities | $159,310 | $144,929 | $142,724 | $133,686 | $128,785 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,533 | 27,449 | 27,336 | 27,190 | 26,982 |
| Common Shares | 32 | 32 | 32 | 32 | 32 |
| Retained earnings | -372,356 | -342,698 | -313,815 | -280,663 | -246,670 |
| Other shareholders' equity | -34 | -264 | -433 | -425 | -363 |
| TOTAL | $63,916 | $89,885 | $114,396 | $142,560 | $169,603 |
| Total Liabilities And Equity | $223,226 | $234,814 | $257,120 | $276,246 | $298,388 |